Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: not including (1000), without (1000)

BRC NMAHP researcher initiation internship award checklist 2023

Description: Name: Proposed Project Title: Contact details: Criteria Email: Mobile: 1. Registration with an appropriate UK regulatory and professional body:
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-NMAHP-researcher-initiation-internship-award-checklist-2023.pdf

Ipilimumab(1mg/kg)-Nivolumab(3mg/kg)

Description: Chemotherapy Protocol RENAL CANCER IPILIMUMAB (1mg/kg)-NIVOLUMAB(3mg/kg) Regimen • Renal – Ipilimumab (1mg/kg)-Nivolumab (3mg/kg) Indication • Ipilimumab in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Ipilimumab1mgkg-Nivolumab3mgkg.pdf

Bendamustine-Polatuzumab-Rituximab

Description: Chemotherapy Protocol LYMPHOMA BENDAMUSTINE-POLATUZUMAB-RITUXIMAB Regimen • Lymphoma – Bendamustine-Polatuzumab-Rituximab Indication • Histologically diagnosed diffuse large B cell lymphoma (DLBCL) including
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Polatuzumab-Rituximab.pdf

Dexamethasone(40)-Pomalidomide

Description: Regimen Chemotherapy Protocol Myeloma Dexamethasone (40)-Pomalidomide • Myeloma – Dexamethasone (40)-Pomalidomide Indication • Pomalidomide, in combination with dexamethasone, is recommended as an
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-40-Pomalidomide.pdf

Dexamethasone(20)-Pomalidomide

Description: Chemotherapy Protocol Myeloma Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Dexamethasone (20)-Pomalidomide Indication • Pomalidomide, in combination with low‑dose dexamethasone, is recommended
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-20-Pomalidomide.pdf

Clarithromycin-Dexamethasone_40_Pomalidomide

Description: Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (40)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (40)-Pomalidomide Indication • Pomalidomide, in combination with dexamethasone, is recommended
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-40-Pomalidomide.pdf

Clarithromycin-Dexamethasone_20_Pomalidomide

Description: Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (20)-Pomalidomide Indication • Pomalidomide, in combination with low‑dose dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-20-Pomalidomide.pdf

UHS ICE RADIOLOGY REQUESTING FOR GP SURGERIES

Description: ICE Radiology
Url: /Media/UHS-website-2019/Docs/Services/Pathology/ICE/UHS-ICE-RADIOLOGY-REQUESTING-FOR-GP-SURGERIES.pdf

Press release: Doctors develop comic sequel for diabetes patients

Description: A sequel to a comic developed by diabetes experts in Southampton and Portsmouth to help young patients' understanding of the condition
Url: /AboutTheTrust/Newsandpublications/Latestnews/2018/November-2018/Press-release-Doctors-develop-comic-sequel-for-diabetes-patients.aspx

Clinical case tutorial key learning points

Description: Auto Generated Title HbA1c is now recommended by WHO, BDA, ADA, ACB, NICE and other international bodies for the screening and diagnosis of diabetes. Its major advantage is that
Url: /HealthProfessionals/BiochemistrytutorialforGPs/Tutorialarchive/Clinicalcasetutorialfour/Clinicalcasetutorialkeylearningpoints.aspx

61 to 70 of 249

Previous … 5 6 7 8 9 … Next